Skip to main content
. 2011 Jan 26;60(5):629–638. doi: 10.1007/s00262-011-0970-1

Table 1.

Physical properties of the vaccine formulations

Formulation Particle size (nm)* Zeta potential (mV)** Encapsulation efficiency (%)***
R-DOTAP/E7 126.8 ± 5.1 54.3 ± 4.0 31.3 ± 16.6
S-DOTAP/E7 125.6 ± 7.8 55.8 ± 1.9 32.1 ± 8.9

Lipid concentration used in these studies was 6 mM, equivalent to 300 nmol of lipid per mouse

P = 0.69, n = 8–10

** P = 0.37, n = 8–10

*** P = 0.87, n = 13–14